Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Monoclonal Antibodies Specific to Mycoplasma genitalium Available

By LabMedica International staff writers
Posted on 12 Jul 2012
A set of four monoclonal antibodies that are specific to Mycoplasma genitalium has been released. More...
They do not cross react with other Mycloplasmas and/or related bacteria.

The antibodies function in the enzyme-linked immunosorbent assay (ELISA) and indirect fluorescence assay (IFA) and are available for research and assay development.

Mycoplasma genitalium is a small bacterium without a cell wall. It resides in the human urogenital tract where it obtains its nutrients and causes urethritis in males and females as well as pelvic inflammatory disease (PID) in females.

ViroStat (Portland, ME, USA) released the four monoclonal antibodies. These may be used for assay development but meanwhile they are not yet available for diagnostic purposes. The data sheet, including pricing, for the antibodies can be found at the ViroStat website.

ViroStat, Inc. is a primary manufacturer of infectious disease antigens and antibodies. These include high affinity antibodies to Flu A, Flu B, Respiratory syncytial virus (RSV) and Streptococcus A for use in rapid lateral flow devices as well as antibodies to food-borne pathogens and toxins. Also, many specificities to Hepatitis C virus (HCV), Hepatitis B virus (HBV), Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) are available for use in antiviral high-throughput screening assays (HTS) assays.

Related Links:

ViroStat



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.